ORS 646A.697: Study of market for generic drugs; effect of pricing on insurance premiums; report to Legislative Assembly.

(1) As used in this section, “generic drug” means:

      (a) A retail drug that is marketed or distributed in accordance with an abbreviated new drug application approved under 21 U.S.C. 355(j);

      (b) An authorized generic as defined by 42 C.F.R. 447.502; or

      (c) A drug that entered the market before 1962 that was not originally marketed under a new drug application.

      (2) The status of the generic drug market includes but is not limited to:

      (a) The prices of generic drugs on a year-to-year basis;

      (b) The degree to which generic drug prices affect insurance premiums;

      (c) Annual changes in health insurance cost-sharing for generic drugs;

      (d) The potential for and history of generic drug shortages; and

      (e) The degree to which generic drug prices affect annual spending in the state medical assistance program. [2021 c.598 §6; 2025 c.166 §4]

MORTGAGE RESCUE FRAUD PREVENTION ACT

(Foreclosure Consultants)